# Prevention of Left Ventricular Dysfunction During Chemotherapy

> **NCT01110824** · PHASE3 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 90 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Precursor-cell Lymphoblastic Leukemia-Lymphoma
- Lymphoid Neoplasm
- Multiple Myeloma
- Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Enalapril and carvedilol

## Key facts

- **NCT ID:** NCT01110824
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-12
- **Final completion:** 2012-03
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2013-11-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110824, "Prevention of Left Ventricular Dysfunction During Chemotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01110824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*